Previous 10 | Next 10 |
Channelchek news releases related Channelchek news releases and Channelchek press releases from 06/11/21 12:00:00 on US and Canada Markets.
Biogen’s Alzheimer drug Aducanumab was approve amidst much debate. The Food and Drug Administration (FDA) grants accelerated approvals for drugs to treat serious illnesses for which there are no known, or very few, treatments. Was the drug to be marketed as Aduhelm incorrectly made avai...
Biogen’s Alzheimer drug Aducanumab was approve amidst much debate. The Food and Drug Administration (FDA) grants accelerated approvals for drugs to treat serious illnesses for which there are no known, or very few, treatments. Was the drug to be marketed as Aduhelm incorrectly made avai...
Biogen’s Alzheimer drug Aducanumab was approve amidst much debate. The Food and Drug Administration (FDA) grants accelerated approvals for drugs to treat serious illnesses for which there are no known, or very few, treatments. Was the drug to be marketed as Aduhelm incorrectly made avai...
Over the next two Fridays, The FTSE Russell will post updates to its equity index reconstitutions that were announced last Friday. These updates and adjustments to the original lists provided could occur for a number of reasons. The reactions to stock prices impacted could be strong as these a...
Over the next two Fridays, The FTSE Russell will post updates to its equity index reconstitutions that were announced last Friday. These updates and adjustments to the original lists provided could occur for a number of reasons. The reactions to stock prices impacted could be strong as these a...
Over the next two Fridays, The FTSE Russell will post updates to its equity index reconstitutions that were announced last Friday. These updates and adjustments to the original lists provided could occur for a number of reasons. The reactions to stock prices impacted could be strong as these a...
Over the next two Fridays, The FTSE Russell will post updates to its equity index reconstitutions that were announced last Friday. These updates and adjustments to the original lists provided could occur for a number of reasons. The reactions to stock prices impacted could be strong as these a...
Plans to acquire MediaDonuts. The acquisition of MediaDonuts, which is expected to close July 1st, will establish the company as a Digital Marketing company in Southeast Asia, moving beyond its traditional Hispanic oriented media businesses. We estimate that the acquisition in total will be ro...
Investor Forum at the World Stem Cell Summit - June 17, 2021 - presented by Channelchek - Featuring Avalon GloboCare, Caladrius Biosciences, CellZ, Celularity, ExoProTher, GID BIO, Longeveron, Medicinal Cells, Inc., Mesoblast Read More >>
Over the next two Fridays, The FTSE Russell will post updates to its equity index reconstitutions that were announced last Friday. These updates and adjustments to the original lists provided could occur for a number of reasons. The reactions to stock prices impacted could be strong as these a...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
18.48%Change Percent:
Procore Technologies Inc. Company Name:
PCOR Stock Symbol:
NYSE Market:
procore.com Website: